Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Three Patients with Angle Closure: A Case Series.

Q3 Medicine
Journal of Current Glaucoma Practice Pub Date : 2024-07-01 Epub Date: 2024-10-29 DOI:10.5005/jp-journals-10078-1449
James Richardson-May, Sameh A Ibrahim, Kitty Law, Abeir Baltmr, Ahmed Elbably
{"title":"Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Three Patients with Angle Closure: A Case Series.","authors":"James Richardson-May, Sameh A Ibrahim, Kitty Law, Abeir Baltmr, Ahmed Elbably","doi":"10.5005/jp-journals-10078-1449","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim and background: </strong>The OMNI surgical system allows for 360° canaloplasty and trabeculotomy for patients with glaucoma, either as a standalone procedure or in combination with cataract surgery. There is currently limited evidence on its use in forms of angle-closure glaucoma, though other microinvasive glaucoma surgeries have been used. We present three patients with angle closure who underwent the procedure.</p><p><strong>Methods: </strong>Retrospective review of three patients who underwent canaloplasty and trabeculotomy with the OMNI surgical system with forms of angle closure. Data on demographics, intraocular pressure (IOP), glaucoma medication use, best corrected visual acuity (BCVA), visual fields (VFs), and complications were collected for a 6-month period.</p><p><strong>Results: </strong>Three eyes of three patients underwent the procedure: one with primary angle closure glaucoma (PACG), one acute angle closure, and one primary angle closure (PAC). All had surgery combined with phacoemulsification and intraocular lens (IOL) implantation. The mean age was 56 years. Preoperative IOP was 25.33 ± 2.49 mm Hg, improving to 11.67 ± 2.87 mm Hg at 6 months. Mean glaucoma medication use was reduced by 3.00, from 3.67 ± 1.21 to 0.67 ± 0.94. Preoperative mean BCVA was 0.10 ± 0.08 and 0.20 ± 0.08 LogMAR at 6 months. Mean deviation (MD) on VFs was -9.67 preoperatively and -6.72 at 6 months. Two patients had mild, self-limiting hyphema postoperatively which resolved without further intervention; no other complications were reported.</p><p><strong>Conclusion: </strong>We have found the OMNI surgical system to be a safe, effective tool in the management of angle-closure glaucomas in a small cohort of patients.</p><p><strong>Clinical significance: </strong>The OMNI surgical system has the potential to add a less invasive surgical solution in the management of angle closure glaucoma, prior to the use of filtering surgery such as trabeculectomy or glaucoma drainage device. Larger trials assessing the use of microinvasive glaucoma surgery (MIGS) in these patients will be eagerly received.</p><p><strong>How to cite this article: </strong>Richardson-May J, Ibrahim SA, Law K, <i>et al.</i> Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Three Patients with Angle Closure: A Case Series. J Curr Glaucoma Pract 2024;18(3):117-120.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":"18 3","pages":"117-120"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11576345/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Glaucoma Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10078-1449","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Aim and background: The OMNI surgical system allows for 360° canaloplasty and trabeculotomy for patients with glaucoma, either as a standalone procedure or in combination with cataract surgery. There is currently limited evidence on its use in forms of angle-closure glaucoma, though other microinvasive glaucoma surgeries have been used. We present three patients with angle closure who underwent the procedure.

Methods: Retrospective review of three patients who underwent canaloplasty and trabeculotomy with the OMNI surgical system with forms of angle closure. Data on demographics, intraocular pressure (IOP), glaucoma medication use, best corrected visual acuity (BCVA), visual fields (VFs), and complications were collected for a 6-month period.

Results: Three eyes of three patients underwent the procedure: one with primary angle closure glaucoma (PACG), one acute angle closure, and one primary angle closure (PAC). All had surgery combined with phacoemulsification and intraocular lens (IOL) implantation. The mean age was 56 years. Preoperative IOP was 25.33 ± 2.49 mm Hg, improving to 11.67 ± 2.87 mm Hg at 6 months. Mean glaucoma medication use was reduced by 3.00, from 3.67 ± 1.21 to 0.67 ± 0.94. Preoperative mean BCVA was 0.10 ± 0.08 and 0.20 ± 0.08 LogMAR at 6 months. Mean deviation (MD) on VFs was -9.67 preoperatively and -6.72 at 6 months. Two patients had mild, self-limiting hyphema postoperatively which resolved without further intervention; no other complications were reported.

Conclusion: We have found the OMNI surgical system to be a safe, effective tool in the management of angle-closure glaucomas in a small cohort of patients.

Clinical significance: The OMNI surgical system has the potential to add a less invasive surgical solution in the management of angle closure glaucoma, prior to the use of filtering surgery such as trabeculectomy or glaucoma drainage device. Larger trials assessing the use of microinvasive glaucoma surgery (MIGS) in these patients will be eagerly received.

How to cite this article: Richardson-May J, Ibrahim SA, Law K, et al. Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Three Patients with Angle Closure: A Case Series. J Curr Glaucoma Pract 2024;18(3):117-120.

使用 OMNI 手术系统对三例角膜闭合患者进行瞳孔成形术和小梁切开术:病例系列。
目的和背景:OMNI 手术系统可为青光眼患者进行 360° 角膜管成形术和小梁切开术,既可单独进行,也可与白内障手术结合使用。尽管其他微创青光眼手术也曾使用过该系统,但目前将其用于各种形式的闭角型青光眼的证据还很有限。我们介绍了接受该手术的三位闭角型青光眼患者:方法:回顾性分析三例使用 OMNI 手术系统进行管成形术和小梁切开术的闭角型青光眼患者。收集了6个月内的人口统计学、眼压(IOP)、青光眼药物使用、最佳矫正视力(BCVA)、视野(VFs)和并发症等数据:三名患者的三只眼睛接受了手术:一只患有原发性闭角型青光眼(PACG),一只患有急性闭角型青光眼,一只患有原发性闭角型青光眼(PAC)。所有患者都接受了联合超声乳化和人工晶体植入手术。平均年龄为 56 岁。术前眼压为 25.33 ± 2.49 mm Hg,6 个月后降低到 11.67 ± 2.87 mm Hg。青光眼平均用药量减少了 3.00 次,从 3.67 ± 1.21 降至 0.67 ± 0.94。术前 BCVA 平均值为 0.10 ± 0.08,6 个月时为 0.20 ± 0.08 LogMAR。术前 VF 平均偏差 (MD) 为 -9.67,6 个月时为 -6.72。两名患者术后出现轻度、自限性眼底出血,无需进一步干预即可缓解;未报告其他并发症:结论:我们发现 OMNI 手术系统是治疗小部分患者闭角型青光眼的一种安全、有效的工具:临床意义:在使用小梁切除术或青光眼引流装置等滤过手术之前,OMNI 手术系统有可能为闭角型青光眼的治疗增加一种创伤较小的手术方案。我们期待更大规模的试验来评估微创青光眼手术(MIGS)在这些患者中的应用:Richardson-May J、Ibrahim SA、Law K 等:《使用 OMNI 手术系统对三例房角闭合患者进行房角成形术和小梁切开术》:病例系列。J Curr Glaucoma Pract 2024;18(3):117-120.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Current Glaucoma Practice
Journal of Current Glaucoma Practice Medicine-Ophthalmology
CiteScore
1.00
自引率
0.00%
发文量
38
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信